Low‑Sugar Beverages and Metabolic Health

Low‑sugar beverages have moved from a “better‑for‑you” niche to a mainstream growth engine because metabolic health has become a mass‑market concern: global obesity and diabetes burdens are rising, and consumers increasingly treat sugar reduction as a daily habit rather than a periodic “diet.”

The market is bifurcating into two winning product architectures: (1) zero‑sugar, full‑flavor replicas of classic sodas and energy/hydration drinks; and (2) lightly sweetened, “metabolic‑friendly” beverages that aim to stay under tax/label thresholds while adding satiety or functional cues (fiber, protein, “cleaner” sweetener systems).

Ingredient innovation is accelerating—but regulatory fragmentation is now a decisive competitive factor.

The United States’ approach to allulose labeling enables “sugar‑looking” sweetness without “sugar” on the label, while the EU’s novel‑food posture has (so far) constrained allulose scale‑up; conversely, the EU has advanced approvals for some fermentation‑derived steviol glycosides, widening the toolkit for sugar reduction.

Policy pressure is intensifying via sugar taxes and front‑of‑pack/graded labeling systems (especially in Europe and parts of Asia), shifting R&D toward precisely engineered sugar thresholds (e.g., per‑100ml rules) and reformulation of “historically sugary” segments like ready‑to‑drink coffee and milk‑based beverages.

Commercial upside is substantial—especially in “modern soda” and functional low‑sugar refreshment—but risk is rising in three areas: taste parity costs, sweetener controversy (science + perception), and claims/label litigation (especially around gut‑health and “zero sugar”).

Why low‑sugar is accelerating now

Metabolic health has become an organizing principle for food and beverage choices—not only for “weight loss,” but also for perceived energy stability, glucose control, and long‑term risk reduction. That shift is occurring against a clear epidemiological backdrop: the World Obesity Atlas 2024 projects adults living with obesity rising from 0.81 billion (2020) to 1.53 billion (2035), with global overweight/obesity reaching 54% of adults by 2035 on current trends.

In parallel, the International Diabetes Federation estimates ~589 million adults (20–79) lived with diabetes in 2024, projecting ~853 million by 2050, alongside large undiagnosed populations.  This matters for drinks because beverages are one of the easiest, most habitual vectors for reducing added/free sugars without changing meal patterns.

Consumer intent data in the 2024–2026 period reinforces this.

In the 2024 Food & Health Survey, the International Food Information Council found more consumers reporting they are trying to limit sugar (66% in 2024 vs. 61% the prior year), with motivations increasingly linked to avoiding weight gain and preventing future health conditions.  Its 2025 sugars/sweeteners brief adds that, among those limiting sugars, the most common action remains choosing water over caloric beverages, while “reduced sugar” and “sugar‑free” buying behaviors have grown versus earlier survey years.  (These surveys are U.S.‑centric; globally, the same direction shows up through tax policy and multinational portfolio moves rather than a single harmonized consumer dataset.)

Finally, policy and price signals increasingly push beverages toward sugar reduction. The World Health Organization continues to promote fiscal measures (“health taxes”) as part of NCD prevention, and in early 2026 highlighted how low taxation can keep sugary drinks affordable, launching a “3 by 35” push for major price rises through excise taxes over a decade.  Meanwhile, in settings such as the UK, tightening sugar‑tax thresholds and expanding scope (e.g., to milk‑based drinks) create a direct reformulation mandate for manufacturers.

Market landscape and category trajectories

Market sizing and growth signals

Because “low‑sugar” is not a single standardized category (some analysts include only “zero sugar,” others include broader low‑calorie and reduced‑sugar beverages), market estimates vary materially. One widely cited research estimate from Fortune Business Insights values the global zero‑sugar beverages market at US$71.94B in 2025, projecting US$79.48B in 2026 and rapid growth thereafter.  These numbers should be read as directional: they reflect the scale and investor attention, not a universally agreed market boundary.

In the U.S., where retail measurement firms actively track emerging beverage “micro‑categories,” Circana describes “modern soda” (health‑forward soda alternatives, typically low sugar and function‑positioned) as a US$1.8B category with 83% year‑over‑year dollar sales growth.  That is a critical signal: incremental growth is increasingly coming from new architectures (fiber + function + low sugar), not only from legacy diet sodas.

Category playbooks that are winning

Zero/low‑sugar colas and flavored carbonates.

The strongest proof point is performance inside the largest legacy platforms. **The Coca-Cola Company reported Coca‑Cola Zero Sugar grew 14% for full year 2025 (and 13% for the fourth quarter), underscoring sustained global momentum rather than a one‑market fad.  In the same period, **PepsiCo pointed to double‑digit net revenue growth and market share gains for Pepsi Zero Sugar, supported by taste‑challenge marketing.

Lightly sweetened beverages.

As sugar taxes tighten and consumer skepticism of some sweeteners grows, brands are increasingly choosing a “low‑but‑not‑zero” approach that preserves taste and mouthfeel while keeping calories low enough to fit weight‑management narratives. PepsiCo’s remarks describing Pepsi Prebiotic—30 calories, 5g sugar, 3g prebiotic fiber, no artificial sweeteners, selling out rapidly at launch—illustrate this strategy: a controlled sugar dose plus fiber and a clean‑label framing.

Reformulated RTD coffee/tea and milk‑based drinks.

This segment is structurally pressured because many RTD coffees (and bottled milk coffees) historically relied on sugar for palatability. Regulatory scope expansion makes reformulation non‑optional. The UK has moved to end sugar‑tax exemptions for pre‑packaged milk‑based drinks and sweetened plant‑based alternatives from 2028 and to lower the threshold that triggers the levy.  This type of rule change tends to ripple through multinational recipe standards because companies aim to avoid running dozens of country‑specific SKUs.

Functional low‑sugar drinks.

“Gut health,” satiety, and “metabolic support” (often via fiber) are being used to justify premium pricing while keeping sugar low. This is also where claims risk is highest, because benefits are implied even when dosing is modest.

Brief case studies

Case study: Poppi (functional soda → strategic acquisition). A major signal of strategic value is PepsiCo’s acquisition of Poppi for US$1.95B (net purchase price lower after expected tax benefits), positioning “healthier soda” as a portfolio priority rather than an experiment.  In prepared remarks, PepsiCo cited 2025 estimated retail sales of nearly US$745M, >45% growth vs. 2024, and framed Poppi as resonating with consumers within both liquid refreshment beverage and CSD categories.  The brand’s formulation and story (prebiotics + fruit juice + apple cider vinegar in a low‑calorie soda format) fits the lightly sweetened + function thesis, but the category also faces elevated scrutiny: Poppi has confronted litigation challenging the strength of its gut‑health marketing claims.

Case study: Olipop (premium low‑sugar + fiber + scale). Olipop’s trajectory shows how low‑sugar can be a premiumization lever when paired with functional ingredients. The company stated it turned profitable in 2024, with sales doubling to US$400M, and raised funding valuing it at US$1.85B.  It positions itself explicitly as a healthier alternative to sugar‑laden soda with 5g sugar and <50 calories, and emphasizes prebiotic fiber sources (e.g., chicory root and others) to support gut‑health positioning.  The commercial lesson for startups: low sugar is necessary but not sufficient—distribution expansion, flavor velocity, and brand storytelling are what turn “macro trend” into repeat purchase.

Case study: Coca‑Cola Zero Sugar (replica strategy + global scaling). Zero‑sugar replicas win when they remove the taste compromise and fit mainstream occasions. Coca‑Cola’s own reporting of double‑digit growth for Coca‑Cola Zero Sugar in 2025 signals that “diet” is being re‑coded as “modern cola” rather than “sacrifice product.”  Trade reporting on Latin American bottling operations also suggests that even in historically full‑sugar strongholds, sugar‑free cola can gain meaningful traction (e.g., reported growth in Mexico for Coca‑Cola Zero Sugar).

Sweeteners, ingredients, and formulation technology

The formulation problem to solve

Sugar in beverages is not only sweetness—it also contributes to body, aroma release, acid balance, and repeatable flavor perception. Removing it creates three technical deficits: (1) sweetness quality (aftertaste, bitterness), (2) mouthfeel/thickness, and (3) “temporal profile” (how sweetness and acidity unfold over time). This is why many successful low‑sugar products rely on systems, not single ingredients: blended sweeteners, acid systems, flavor modulators, and texture rebuilders.

Notable sweeteners and where they fit

Stevia (and improved steviol glycosides).

Steviol glycosides remain central because they support “plant‑based” and “natural” positioning, but classic stevia profiles can have bitterness/lingering. The industry response has focused on better‑tasting minor glycosides like Reb M / Reb D and on manufacturing routes that make them economically viable. A key regulatory milestone: the EU has authorized steviol glycosides from fermentation (E 960b), including specifications for Reb M produced using fermentation (and related regulatory updates).  On the supply side, ingredient producers emphasize fermentation‑enabled access to these minor glycosides and “sugar‑like” taste claims in commercial launches.

Monk fruit.

Monk fruit can help with “from nature” narratives and may work well in blends (often with stevia), but regulatory status is inconsistent. Peer‑reviewed analysis notes monk fruit extracts have only been partially authorized in the EU context (with limitations by extract type and data gaps), constraining broad beverage deployment versus the U.S.

Allulose (rare sugar). 

Allulose is strategically attractive because it behaves more like sugar in some functional respects (taste and bulking contribution) while contributing minimal calories and limited glycemic impact relative to sucrose. The U.S. regulatory environment is a major tailwind: the U.S. Food and Drug Administration issued guidance describing enforcement discretion that allows excluding allulose from “Total Sugars” and “Added Sugars” declarations under specified conditions, and also addresses caloric value assumptions (e.g., up to 0.4 kcal/g in labeling contexts).

However, Europe remains challenging: the European Food Safety Authority concluded in 2025 that the safety of D‑allulose as a novel food could not be established based on the available data, which slows EU adoption.  Meanwhile, regional “sweetener industrial policy” matters: reporting on South Korea describes significant investment in allulose production, including supply to major beverage players, despite current cost premiums versus sugar.

Erythritol (polyol) and the safety‑perception trap. Polyols are useful for bulking and “sugar‑free” positioning, but the risk landscape has shifted: academic and clinical reporting continues to explore associations between higher erythritol exposure markers and cardiovascular outcomes, and prominent medical‑institution communications have amplified public attention.  This does not automatically translate into regulatory prohibition, but it elevates reputational and litigation risk—especially for brands positioning products as “heart‑healthy” or “daily metabolic support.”

Tools beyond sweeteners: taste modulation, fiber, protein, and “metabolic cues”

Taste‑masking and modulation technologies—often delivered by flavor houses—aim to suppress bitterness, improve sweetness onset, and reduce lingering effects. While many technical details are proprietary, the direction is clear: flavor/taste “technology stacks” are becoming as important as the sweetener itself in achieving sugar‑level taste acceptance.

Fiber for satiety and glycemic framing. Soluble fibers (e.g., inulin/chicory root fiber or other sources) are being used in low‑sugar sodas to rebuild mouthfeel and add a satiety/gut‑health cue; Olipop and Poppi exemplify commercial adoption.  This strategy also helps justify premium pricing and differentiates from legacy diet sodas.

Protein and “high‑protein lifestyles.” Protein claims often sit adjacent to low‑sugar positioning in weight‑management narratives. IFIC’s 2024 survey shows rising consumer efforts to consume protein, and weight loss/management remains a major benefit sought from foods and beverages—helping explain why “low sugar + protein” portfolios are expanding.

Scientific nuance: do non‑sugar sweeteners “work” for weight management?

This is a critical tension for the low‑sugar beverage industry in 2024–2026.

• The WHO issued guidance recommending against using non‑sugar sweeteners as a means of weight control or reducing NCD risk, reflecting concerns about longer‑term outcomes in some evidence streams.
• At the same time, peer‑reviewed assessments and trials often show that replacing sugar‑sweetened beverages with non‑caloric alternatives yields small but measurable improvements in weight‑related outcomes, especially compared with continuing sugar‑sweetened intake. A 2024 obesity‑journal analysis reports BMI reductions when substituting sugar‑sweetened beverages with non‑caloric beverages.  A 2024 commentary highlights an RCT in which participants assigned to non‑nutritive‑sweetened beverages achieved slightly greater weight loss than those assigned to water over a year.  A 2025 review similarly characterizes average effects as modest relative to medications or intensive programs.

For producers, the implication is practical: “zero sugar” can be part of a weight‑management strategy, but it is not a guaranteed outcome and should be marketed carefully—leaning on taste, calorie reduction, and substitution logic rather than medical promises.

Regional regulation and policy environment

Europe

Europe’s policy environment is increasingly structural for beverage portfolios: sugar taxes, marketing restrictions, and package/label regulations create hard constraints that drive reformulation at scale.

In the United Kingdom, the government has reviewed and moved to strengthen the Soft Drinks Industry Levy, including lowering sugar thresholds and removing some exemptions (with implementation timelines extending into 2028 for certain changes).  Academic evaluation suggests fiscal levers can deliver material sugar reductions: a 2024 review notes the UK levy achieved a large reduction in total sugar sales from soft drinks, outperforming voluntary sugar reduction programs.

The European ingredient approval map is also differentiating. The EU’s authorization of fermentation‑derived steviol glycosides expands “natural” options for sugar reduction.  Conversely, allulose remains constrained by the EFSA novel‑food finding that safety could not be established from available data.

United States

The United States has two characteristics that shape low‑sugar beverage strategy: (1) strong consumer innovation demand (modern soda, functional beverages, private label soda), and (2) a comparatively permissive sweetener toolkit plus labeling pathways that can favor certain ingredients.

The FDA’s allulose guidance is a cornerstone enabling “sugar‑like” product architecture while keeping label sugars low, which is commercially powerful in a label‑driven market.  At the same time, the U.S. is a high‑litigation environment for functional and “zero” claims. A Reuters legal report on “zero sugar” labeling disputes (in a non‑beverage example) illustrates how definitions and FDA guidance can become central in consumer‑protection lawsuits.

Asia

Asia is not homogeneous; three patterns stand out where data is strongest:

• Threshold‑based labeling regimes can be highly directive. In Singapore, a whole‑of‑government healthier food and beverage policy ties beverage acceptability to Nutri‑Grade thresholds—e.g., ≤5g free sugar per 100ml for certain settings—creating a formulation target that is more explicit than many Western markets.
• Sweetener industrialization is emerging. Reporting on South Korea describes rapid investment in allulose manufacturing capacity and supply relationships with beverage companies, despite higher costs than sugar—positioning the country as an allulose hub.
• Policy expansion is ongoing: Singapore’s Ministry of Health has also announced extensions of Nutri‑Grade measures to additional nutrient concerns over time, indicating that graded labeling frameworks can broaden beyond sugar.

Where public data is limited (parts of Asia beyond Singapore/Korea or in many emerging markets), a conservative assumption is that multinational companies will prioritize portable, modular formulations (sweetener and flavor systems that can be swapped by region) to manage regulatory variance without proliferating SKUs.

Supply chain, packaging, and sustainability considerations

Low‑sugar beverages are often discussed as a health beverages trend, but operational realities increasingly determine which concepts can scale profitably.

Sweetener sourcing and cost stability

“Natural” sweetener systems face agricultural concentration and processing capacity constraints; fermentation‑based routes (for some steviol glycosides) are partially a response to both taste and supply predictability, and they align with sustainability narratives.

Allulose highlights a different challenge: even where legally allowed, it may remain a cost‑premium ingredient. Reporting from South Korea describes allulose as substantially more expensive than sugar, which pressures pricing and margin unless brands can command premium positioning or offset with smaller serving sizes.

Sugar policy can reshape upstream inputs

Supply chain risk is not limited to sweeteners. For example, trade disruption affecting sugar syrups and premixes can ripple into beverage ingredient availability and costs—especially where producers rely on cross‑border syrup flows.  While low‑sugar products reduce reliance on sugar inputs, they may substitute toward other constrained ingredients (specialty fibers, high‑purity sweeteners), shifting rather than eliminating supply risk.

Packaging: regulatory compliance and sustainability economics

Packaging is becoming both a compliance issue and a brand trust issue:

• In the European Commission’s single‑use plastics framework, EU beverage containers have faced design requirements such as tethered caps since July 2024, forcing cap redesign, line changes, and consumer‑experience testing.
• Major producers are publishing more detailed packaging metrics. In its 2024 environmental update, Coca‑Cola reports its packages were 99% recyclable globally (by its definition), used 28% recycled material in global primary packaging, and achieved a 65% collection/refill or collection‑for‑recycling rate, while also reporting reusable‑packaging shares and year‑over‑year changes.
• PepsiCo’s packaging agenda includes targets such as reducing virgin plastic tonnage and increasing recycled content over time.

Packaging economics also interact with trade policy. Reporting on Coca‑Cola’s performance has noted that higher tariffs on aluminum imports can push companies to explore packaging cost strategies—a reminder that margins on premium low‑sugar beverages are not insulated from commodity shocks.

Commercial opportunities, risks, and actionable recommendations

Where the opportunities are

Modern soda and functional low‑sugar refreshment remains the standout whitespace: a new category with rapid growth, premium pricing, and brand storytelling that connects low sugar to broader wellness identity.

Reformulation services and enabling ingredients (fermentation‑derived stevia systems, taste modulators, fiber systems) are attractive B2B opportunities because they monetize across many brands, not just one. EU approvals for fermentation‑derived steviol glycosides and ongoing innovation by ingredient suppliers support this investment thesis.

RTD coffee/tea “sugar reset.” As tax scope expands to milk‑based and similar drinks in some markets (notably the UK), manufacturers that can deliver barista‑style taste with materially lower sugar have a structural tailwind.

Risks producers and startups must price in

Claims and litigation risk. The closer a product gets to “health outcome” claims (gut health, metabolic outcomes), the higher the risk of challenges—especially if dosing is low or evidence is indirect. The Poppi lawsuit over gut‑health marketing is a cautionary example for the entire functional low‑sugar segment.

Sweetener trust volatility. WHO guidance cautioning against non‑sugar sweeteners for weight control can amplify consumer skepticism, even when product substitution evidence supports some benefits versus sugar‑sweetened alternatives.  Erythritol’s evolving research debate adds another layer of reputational risk for “sugar‑free” positioning.

Regulatory fragmentation. A formulation that is “perfect” for the U.S. (e.g., allulose‑enabled low label sugar) may not be deployable in the EU; a sweetener system optimized for EU additive approvals may require different labeling narratives elsewhere.

Actionable recommendations for manufacturers

Prioritize a portfolio architecture rather than a single “hero” approach: offer a sugar ladder (zero sugar; very low sugar; lightly sweetened) so consumers can trade off taste, ingredients, and perceived naturalness by occasion.

Engineer for policy thresholds early in development (per‑100ml rules, tax bands, graded labels). Build formulations that can be “dialed” from 4–6g/100ml without collapsing taste—this reduces costly late reformulation when regulations tighten.

Invest in taste systems, not only sweeteners: sweetness temporal profile, bitterness suppression, and mouthfeel rebuilding should be treated as core IP. Fermentation‑derived steviol glycosides (where permitted) and structured blends can reduce off‑notes and improve repeat purchase.

Use function cues responsibly: fiber and protein can support satiety narratives, but avoid implying disease or guaranteed weight outcomes. Build claims substantiation files and align marketing language with the strictest target region to reduce litigation exposure.

Align low‑sugar innovation with packaging compliance and sustainability (tethered caps where relevant; recycled content; refillable where feasible). Consumers increasingly view “health” and “planet” as a combined trust bundle.

Actionable recommendations for investors

Underwrite regulatory optionality as a financial asset: brands dependent on a single sweetener with uncertain cross‑regional approval (e.g., allulose in Europe) carry hidden expansion risk.

Treat velocity + repeat as the moat, not novelty. Modern soda has demonstrated category‑level growth; the winners will be those that convert trial into habit through taste, price‑pack architecture, and credible positioning.

Price in claims scrutiny and legal cost for functional low‑sugar brands, especially those implying gut or metabolic outcomes. A disciplined compliance posture can be a competitive advantage, not a cost center.